Epidemiology of Prediabetes

Medical Clinics of North America

Volumn 95, Issue 2, 2011, Pages 299-307

  Colagiuri, Stephen ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Prediabetes; Prevalence; Risk assessment; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; WAIST CIRCUMFERENCE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PREDIABETIC STATE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 79251538940     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.11.003     Document Type: Review

References (38)

1. World Health Organization Diabetes mellitus: report of a WHO expert committee 1965, World Health Organisation, Geneva (Switzerland), (Tech. Rep. Ser., no. 310). Available at:, Accessed October 9, 2010. http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf.
2. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979, 28:1039-1057.
3. World Health Organization Expert Committee on Diabetes Mellitus 1980, World Health Organisation, Geneva (Switzerland), (Tech. Rep. Ser., no. 646). Available at:, Accessed October 9, 2010. http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf.
4. National Diabetes Data Group, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes Care 1997, 20:1183-1197.
5. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus 1999, World Health Organisation, Geneva (Switzerland).
6. Colagiuri S., Borch-Johnsen K., Wareham N.J. Back to the future - Do IGT and IFG have value as clinical entities?. Diabetes Res Clin Pract 2008, 81:131-133.
7. Diabetes atlas 2009, International Diabetes Federation, Brussels (Belgium), Available at:, Accessed October 9, 2010. http://www.diabetesatlas.org/, 4th edition.
8. Yang W., Lu J., Weng J., for the China National Diabetes and Metabolic Disorders Study Group, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362:1090-1101.
9. DECODE Study Group Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European Cohorts. Diabetes Care 2003, 26:61-69.
10. Qiao Q., Hu G., Tuomilehto J., et al. DECODA Study Group. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian Cohorts. Diabetes Care 2003, 26:1770-1780.
11. World Health Organization Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia 2006, World Health Organisation, Geneva (Switzerland), Available at:, Accessed October 9, 2010. http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf.
12. Genuth S., Alberti K.G., Bennett P., The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
13. Borch-Johnsen K., Colagiuri S., Balkau B., et al. Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 2004, 47:1396-1402.
14. McMaster University Evidence Based Practice Center Diagnosis, prognosis and treatment of impaired glucose tolerance and impaired fasting glucose, Evidence Report 128 Available at:, Accessed October 9, 2010. http://www.ahrq.gov.
15. Edelstein S.L., Knowler W.C., Bain R.P., et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997, 46:701-710.
16. Gabir M.M., Hanson R.L., Dabelea D., et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000, 23:1108-1112.
17. Forouhi N.G., Balkau B., Borch-Johnsen K., et al. The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group. Diabetologia 2006, 49:822-827.
18. Balkau B., Hillier T., Vierron E., et al. Comment to: Borch-Johnsen K, Colagiuri S, Balkau B, et al (2004). Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47:1396-1402. Diabetologia 2004, 47:1396-1402.
19. Soderberg S., Zimmet P., Tuomilehto J., et al. High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius. J Intern Med 2004, 256:37-47.
20. Levitan E.B., Song Y., Ford E.S., et al. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. JAMA 2005, 293:194-202.
21. Brunner E.J., Shipley M.J., Witte D.R., et al. Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care 2006, 29:26-31.
22. Balkau B., Bertrais S., Ducimetiere P., et al. Is there a glycemic threshold for mortality risk?. Diabetes Care 1999, 22:696-699.
23. DECODE Study Group Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and non-cardiovascular diseases?. Diabetes Care 2003, 26:688-696.
24. International Expert Committee International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
25. American Diabetes Association Clinical Practice Recommendations 2010. Diabetes Care 2010, 33(Suppl 1):S62-S69.
26. Cowie C., Rust K., Byrd-Holt D., et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010, 33:562-568.
27. Ziemer D.C., Kolm P., Weintraub W.S., et al. Glucose-independent, black-white differences in hemoglobin A1c levels. A cross-sectional analysis of 2 studies. Ann Intern Med 2010, 152:770-777.
28. Mann D.M., Carson A.P., Shimbo D., et al. Impact of A1C screening criterion on the diagnosis of prediabetes among U.S. adults. Diabetes Care 2010, 33:2190-2195.
29. Pradhan A.D., Rifai N., Buring J.E., et al. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007, 120(8):720-727.
30. Selvin E., Steffes M.W., Zhu H., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010, 362:800-811.
31. Lindstrom J., Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003, 26:725-731.
32. Aekplakorn W., Bunnag P., Woodward M., et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care 2006, 29:1872-1877.
33. Chen L., Magliano D.J., Balkau B., et al. AUSDRISK: an Australian Type 2 diabetes risk assessment tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust 2010, 192:197-202.
34. Hippisley-Cox J., Coupland C., Robson J., et al. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 2009, 338:b880.
35. Schmidt M.I., Duncan B.B., Bang H., et al. Identifying individuals at high risk for diabetes: the atherosclerosis risk in communities study. Diabetes Care 2005, 28:2013-2018.
36. Schulze M.B., Hoffmann K., Boeing H., et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 2007, 30:510-515.
37. Stern M.P., Williams K., Haffner S.M. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?. Ann Intern Med 2002, 136:575-581.
38. Saaristo T., Peltonen M., Lindstrom J., et al. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res 2005, 2:67-72.